Search for: "Genentech, Inc. v. Sandoz Inc."
Results 1 - 20
of 31
Sorted by Relevance
|
Sort by Date
27 Dec 2022, 7:01 pm
Sandoz Inc. [read post]
22 Dec 2022, 3:15 pm
’s (collectively, “Sandoz’s”) generic product would not induce infringement of the LFT patents, and (3) sale of Sandoz’s generic product would not directly infringe Genentech’s Drug-Drug Interaction (“DDI”) patents.2 See Genentech, Inc. v. [read post]
19 May 2009, 4:23 am
Genentech, Inc. in favor or the contrary panel decision in Atlantic Thermoplastics Co. v. [read post]
10 Jul 2020, 2:12 pm
§§ 1292(a)(1)and (c)(1).(...)Our interpretation is consistent with the SupremeCourt’s decision in Sandoz Inc. v. [read post]
30 Aug 2023, 4:01 pm
” Thus, citing Genentech, Inc. v. [read post]
3 Nov 2023, 7:15 am
The starting point for Mellor J’s analysis was Kitchin LJ’s judgment in Regeneron v Genentech [2013] EWCA Civ 93. [read post]
19 May 2009, 7:34 am
Sandoz, Inc., (Fed. [read post]
6 Jul 2020, 8:49 am
[Sandoz Inc. v. [read post]
8 Dec 2014, 12:42 pm
Genentech, Inc., 549 U.S. 118, 127 (2007). [read post]
29 Jun 2009, 8:52 pm
Genentech, Inc. [read post]
14 Mar 2016, 3:23 am
Hoffmann-La Roche AG and Genentech Inc. | Design v Copyright in Italy | Unitary patent and double patenting | Regeneron Pharmaceuticals Inc v Kymab Ltd & Anor | IKEA in Indonesia | Eli Lilly v Janssen Sciences. [read post]
6 Oct 2010, 4:22 am
Sandoz, Inc. et al (Docket Report) [read post]
9 Feb 2015, 1:15 am
Now, Darren sinks his paws on the appeal decision in Hospira (UK) Ltd v Genentech, Inc [2015] EWCA Civ 57 (6 February 2015). [read post]
23 Sep 2009, 8:31 am
Genentech, Inc. 927 F.2d 1565, 1583 (Fed. [read post]
15 Jun 2011, 4:56 am
Sandoz Inc. et al. [read post]
3 Jun 2010, 5:35 am
– In re Ciprofloxacin Antitrust Litigation (PatLit) Circumvent PCV and Porcilis PCV vaccines – US: Wyeth files patent infringement suit against Intervet based on their manufacture of PCV vaccines (Patent Docs) Copegus (Ribavirin) – US: Ascio seeks declaratory judgment of unenforceability, invalidity and non-infringement of Three Rivers’ patent based on ANDA filing (Patent Docs) Entocort (Budesonide) – US: AstraZeneca settles Entocort patent suit with Teva, stipulates… [read post]
4 Nov 2010, 10:59 am
Genentech, Inc. v. [read post]
24 Nov 2010, 12:37 am
Use of pipeline system (IP tango) EU: Notes from EU Parliament meeting on innovation+access for medical technologies (KEI) Netherlands: District Court of The Hague declares Dutch part of Bayer’s European patent covering anti-TNF alpha human monoclonal antibodies invalid (Kluwer Patent Blog) Southeast Asia: Generic drug market picks up steam in Southeast Asia, finds Front & Sullivan (GenericsWeb) Spain: Commercial Court No 5 of Barcelona: obtaining price for generic medicament an act of… [read post]
14 Oct 2009, 7:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Angiomax (Bivalirudin) – US: Medicines Company files patent infringement suit against PLIVA, Barr, Teva following Para IV challenge (Patent Docs) (America-Israel Patent Law) (The IP Factor) (GenericsWeb) Humira (Adalimumab) – US: E D Texas find ‘close issue of claim construction’ supports JMOL of no… [read post]
11 May 2011, 4:54 am
Allergan, Inc. [read post]
